Pill Identifier App

UriCon

This page contains information on UriCon for veterinary use.
The information provided typically includes the following:
  • UriCon Indications
  • Warnings and cautions for UriCon
  • Direction and dosage information for UriCon

Uricon

This treatment applies to the following species:
Manufacturer: Neogen

Phenylpropanolamine Hydrochloride

50 Mg Chewable Tablets

For Use In Dogs Only

UriCon Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description

UriCon chewable tablets contain 50 mg of phenylpropanolamine hydrochloride. Phenylpropanolamine is an α-adrenergic agonist which has been shown to increase urethral sphincter pressure in dogs. Loss of urethral sphincter tone and decreased sphincter pressure is associated with urinary incontinence in ovariohysterectomized or anestrous dogs.

UriCon Indications

UriCon is indicated for the control of urinary incontinence caused by urethral sphincter incompetence in female dogs.

Dosage & Administration

The recommended dose of UriCon is 3 mg per kg body weight per day, divided into two or three equal oral doses. Some patients may achieve an adequate clinical response with a lower dose. Dosage may be rounded to the nearest 12.5 mg for practical dosing.

Warnings

Not for human use. Keep this and all drugs out of reach of children. UriCon should be avoided or used cautiously in dogs with glaucoma, cardiac disease, hypertension, renal insufficiency, and diabetes mellitus.

Precautions

UriCon should not be administered with other sympathomimetic drugs or tricyclic antidepressants, nor within two weeks of a monoamine oxidase inhibitor because of the risk of acute hypertension. UriCon may increase the risk of cardiac arrhythmias from halogenated gaseous anesthetics. Possible side-effects include restlessness, irritability, tachycardia, hypertension, and anorexia. It may take several days for the full benefit of the drug to be seen. Missed doses may negate the desired effect.

Adverse Reactions

Adverse reactions related to administration of UriCon may include restlessness, irritability, tachycardia, hypertension, urinary retention and anorexia.

Storage

Store between 2°-30°C (36°-86°F). Keep container tightly closed.

How Supplied

UriCon tablets are available in 60 count and 180 count bottles.

For Animal Use Only

Keep Out Of Reach Of Children

NEOGEN Vet™

Manufactured for Neogen® Corporation, Lexington, KY 40511 USA

For more information call: 859/254-1221

02236

L790-1104

Net Contents:

NDC:

Item No.

 

60 tablets

59051-9116-3

09116

010048 L787-1204

180 tablets

59051-9116-0

09117

010049 L788-1204

Nac No.

14910620
NEOGEN CORPORATION
944 NANDINO BLVD, LEXINGTON, KY, 40511-1205
Telephone:   859-254-1221
Order Desk:   800-525-2022
Fax:   859-255-5532
Website:   www.neogen.com
Email:   inform@neogen.com
Every effort has been made to ensure the accuracy of the UriCon information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the UriCon product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web5)